ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

CODX Co Diagnostics Inc

1.11
-0.03 (-2.63%)
Apr 26 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 22,634
Bid Price 1.11
Ask Price 1.17
News -
Day High 1.1799

Low
0.975

52 Week Range

High
1.89

Day Low 1.12
Share Name Share Symbol Market Stock Type
Co Diagnostics Inc CODX NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.03 -2.63% 1.11 15:30:00
Open Price Low Price High Price Close Price Previous Close
1.15 1.12 1.1799 1.11 1.14
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
349 22,634 US$ 1.16 US$ 26,193 - 0.975 - 1.89
Last Trade Type Quantity Price Currency
15:00:00 202 US$ 1.11 USD

Co Diagnostics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
35.01M 31.26M - 6.81M -36.41M -1.16 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Co Diagnostics News

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No CODX Message Board. Create One! See More Posts on CODX Message Board See More Message Board Posts

Historical CODX Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week1.141.181.121.1519,730-0.03-2.63%
1 Month1.131.291.06891.1858,103-0.02-1.77%
3 Months1.181.291.021.1556,797-0.07-5.93%
6 Months1.071.65671.021.2684,6310.043.74%
1 Year1.361.890.9751.2791,955-0.25-18.38%
3 Years8.9911.820.9757.08388,876-7.88-87.65%
5 Years1.0331.400.69411.111,607,0610.087.77%

Co Diagnostics Description

Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV. The company's diagnostics systems enable very rapid, low-cost, sophisticated molecular testing for organisms and genetic diseases by greatly automating historically complex procedures in both the development and administration of tests.

Your Recent History

Delayed Upgrade Clock